Data di Pubblicazione:
2018
Citazione:
Dyslipidaemias in 2017: Atherogenic lipoproteins as treatment targets / A.L. Catapano. - In: NATURE REVIEWS. CARDIOLOGY. - ISSN 1759-5002. - 15:2(2018 Feb), pp. 75-76. [10.1038/nrcardio.2017.221]
Abstract:
Research on dyslipidaemias in 2017 reaffirmed the central role of reducing the levels of atherogenic apolipoprotein B-containing lipoproteins, predominantly LDL, in preventing ischaemic cardiovascular events. However, whether increasing HDL-cholesterol levels in isolation can reduce cardiovascular risk remains to be determined.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
cardiology and cardiovascular medicine
Elenco autori:
A.L. Catapano
Link alla scheda completa: